Features, Health, Biotech, Pharmaceuticals, acquisitions and mergers, BI Prime, Dispensed, Cancer, BI Prime Slideshow, Pfizer,

3 biotechs that investors should buy next after Pfizer’s $11 billion deal for cancer drugmaker Array BioPharma

By

Shutterstock US drug giant Pfizer just announced that it is acquiring biotech Array BioPharma for $11.4 billion.  This latest deal points to a trend of big companies snapping up cancer-focused biotechs, with Merck buying the cancer biotech Tilos Therapeutics for up to $773 million last week. Investors should consider three biotechs that could get a boost […]

MustHaves.LA a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.